López-Menéndez, C. ; Vázquez-Naharro, A. ; Santos, V. ; Dubus, P.; Santamaría, P.G. ; Martínez-Ramírez, Á.; Portillo, F. ; Moreno-Bueno, G. ; Faraldo, M.M.; Cano, A. "E2A modulates stemness, metastasis, and therapeutic resistance of breast cancer."
Kober, K.I.; Cano, A. ; Géraud, C.; Sipilä, K.; Mobasseri, S.A.; Philippeos, C.; Pisco, A.O.; Stannard, A.; Martin, A. ; Salvador, F. ; Santos, V. ; Boutros, M.; Rognoni, E.; Watt, F.M. "Loxl2 is dispensable for dermal development, homeostasis and tumour stroma formation."
Santamaría, P.G. ; Floristán, A. ; Fontanals-Cirera, B.; Vázquez-Naharro, A. ; Santos, V. ; Morales, S. ; Yuste, L. ; Peinado, H. ; García-Gómez, A.; Portillo, F. ; Hernando, E.; Cano, A. "Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability."
Salvador, F. ; Martin, A. ; López-Menéndez, C. ; Moreno-Bueno, G. ; Santos, V. ; Vazquez-Naharro, A.; Santamaría, P.G. ; Morales, S. ; Dubus, P.; Muinelo-Romay, L.; López López, R.; Tung, J.C.; Weaver, V.M.; Portillo, F. ; Cano, A. "Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer."
Cuevas, E.P. ; Eraso, P. ; Mazón, M.J. ; Santos, V. ; Moreno-Bueno, G. ; Cano, A. ; Portillo, F. "LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway."
Villarejo, A. ; Molina-Ortiz, P. ; Montenegro, Y. ; Moreno-Bueno, G. ; Morales, S. ; Santos, V. ; Gridley, T.; Pérez-Moreno, M.A.; Peinado, H. ; Portillo, F. ; Calés, C. ; Cano, A. "Loss of Snail2 favors skin tumor progression by promoting the recruitment of myeloid progenitors."
Martin, A. ; Salvador, F. ; Moreno-Bueno, G. ; Floristán, A. ; Ruiz-Herguido, C.; Cuevas, E.P. ; Morales, S. ; Santos, V. ; Csiszar, K.; Dubus, P.; Haigh, J.J.; Bigas, A.; Portillo, F. ; Cano, A. "Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression."
Díaz-López, A.; Díaz-Martín, J.; Moreno-Bueno, G. ; Cuevas, E.P. ; Santos, V. ; Olmeda, D. ; Portillo, F. ; Palacios, J.; Cano, A. "Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT."
Cuevas, E.P. ; Moreno-Bueno, G. ; Canesin, G.; Santos, V. ; Portillo, F. ; Cano, A. "LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition."
Cubillo, E. ; Diaz-Lopez, A.; Cuevas, E.P. ; Moreno-Bueno, G. ; Peinado, H. ; Montes, A. ; Santos, V. ; Portillo, F. ; Cano, A. "E47 and Id1 interplay in epithelial-mesenchymal transition."
Molina-Ortiz, P. ; Villarejo, A. ; MacPherson, M.; Santos, V. ; Montes, A. ; Souchelnytskyi, S.; Portillo, F. ; Cano, A. "Characterization of the SNAG and SLUG domains of Snail2 in the repression of E-cadherin and EMT induction: modulation by serine 4 phosphorylation."
Moreno-Bueno, G. ; Salvador, F. ; Martín, A. ; Floristán, A. ; Cuevas, E.P. ; Santos, V. ; Montes, A. ; Morales, S. ; Castilla, M.A.; Rojo-Sebastián, A.; Martínez, A.; Hardisson, D.; Csiszar, K.; Portillo, F. ; Peinado, H. ; Palacios, J.; Cano, A. "Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas."
Moreno-Bueno, G. ; Peinado, H. ; Molina, P. ; Olmeda, D. ; Cubillo, E. ; Santos, V. ; Palacios, J.; Portillo, F. ; Cano, A. "The morphological and molecular features of the epithelial-to-mesenchymal transition."
Peinado, H. ; Moreno-Bueno, G. ; Hardisson, D.; Pérez-Gómez, E. ; Santos, V. ; Mendiola, M. ; de Diego, J.I. ; Nistal, M.; Quintanilla, M. ; Portillo, F. ; Cano, A. "Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas."
Email:Info